«As a result, researchers have used the presence of IBs and
heightened kinase activity as a proxy for measuring LRRK2's harmful effects, rather than measuring LRRK2 levels directly,» explained Dr. Finkbeiner.
The prevailing hypothesis has been that misfolded LRRK2 boosts the activity of a type of enzyme called kinase, and that
this heightened kinase activity is what drives cell death.
«As a result, researchers have used the presence of IBs and
heightened kinase activity as a proxy for measuring LRRK2's harmful effects, rather than measuring LRRK2 levels directly,» explained Dr. Finkbeiner, who is the associate director of neurological research at Gladstone as well as a professor at the University of California, San Francisco, with which Gladstone is affiliated.